Assessing Regulatory Risk in Personal Financial Advice Documents: a Pilot Study

Assessing regulatory compliance of personal financial advice is currently a complex manual process. In Australia, only 5%- 15% of advice documents are audited annually and 75% of these are found to be non-compliant(ASI 2018b). This paper describes a pilot with an Australian government regulation agency where Artificial Intelligence (AI) models based on techniques such natural language processing (NLP), machine learning and deep learning were developed to methodically characterise the regulatory risk status of personal financial advice documents. The solution provides traffic light rating of advice documents for various risk factors enabling comprehensive coverage of documents in the review and allowing rapid identification of documents that are at high risk of non-compliance with government regulations. This pilot serves as a case study of public-private partnership in developing AI systems for government and public sector.

Document Chunking and Learning Objective Generation for Instruction Design

Instructional Systems Design is the practice of creating of instructional experiences that make the acquisition of knowledge and skill more efficient, effective, and appealing. Specifically in designing courses, an hour of training material can require between 30 to 500 hours of effort in sourcing and organizing reference data for use in just the preparation of course material. In this paper, we present the first system of its kind that helps reduce the effort associated with sourcing reference material and course creation. We present algorithms for document chunking and automatic generation of learning objectives from content, creating descriptive content metadata to improve content-discoverability. Unlike existing methods, the learning objectives generated by our system incorporate pedagogically motivated Bloom's verbs. We demonstrate the usefulness of our methods using real world data from the banking industry and through a live deployment at a large pharmaceutical company.